GLENMARK PHARMACEUTICALS
看多
已更新

Anchored VWAP Study of Glenmark Pharma

219
[May 22, 2020, Friday EOD analysis]

Anchored VWAP Analysis self explanatory in Chart. Additional Pointers:

- Range Breakout in place
- Breakout accompanied with Expanding volume signaling the Range was an Accumulation Zone
- Stock is also above 5 day EMA , 20 day EMA, 50 day EMA, 65 day EMA (ALL are Sloping upwards and above each other respectively)
- ADX is above 25 on daily chart (trending)

Concern:
-200 day EMA is Sloping down but stock price is above it
- 100 day EMA is above 50 & 65 day EMA but sloping up

Key Target Levels:
1) 370-75
2) 385
3) 399
註釋
correction: It is 200 day MA & not 200 day EMA which I was referring to

Talking about the 200 day EMA:
- the stock price is below it and facing stiff resistance at it since the range was created
- 200 day EMA is also downward sloping
手動結束交易
WILL not be Updating this Idea further...

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。